Bristol-Myers Squibb (BMS) United States of America (USA)
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Bristol-Myers Squibb (BMS) published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
40 | 14.17 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 19 | 4.05 |
Physical Sciences | 2 | 1.22 |
Chemistry | 22 | 10.92 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
7.53 | 15.34 | 18.37 | 15.49 | 18.84 |
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 63.36% Domestic
- 36.64% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Bristol-Myers Squibb (BMS) by Share (132 total)
-
Bristol-Myers Squibb (BMS) and Scripps Research
(10.03)
-
Bristol-Myers Squibb (BMS) and Princeton University
(2.00)
-
Bristol-Myers Squibb (BMS) and Agilent Technologies, Inc.
(1.00)
-
Bristol-Myers Squibb (BMS) and Repertoire Immune Medicines
(1.00)
-
Bristol-Myers Squibb (BMS) and University of Wisconsin-Madison (UW-Madison)
(1.00)
-
Bristol-Myers Squibb (BMS) and Tallac Therapeutics
(0.92)
-
Bristol-Myers Squibb (BMS) and Frontier Medicines Corporation
(0.92)
-
Bristol-Myers Squibb (BMS) and Georgia State University (GSU)
(0.90)
-
Bristol-Myers Squibb (BMS) and Brigham Young University (BYU)
(0.90)
-
Bristol-Myers Squibb (BMS) and The University of Texas MD Anderson Cancer Center
(0.87)
Top 10 international collaborators with Bristol-Myers Squibb (BMS) by Share (152 total)
-
Bristol-Myers Squibb (BMS) and F. Hoffmann-La Roche AG
(3.09)
-
Bristol-Myers Squibb (BMS) and The University of British Columbia (UBC)
(1.00)
-
Bristol-Myers Squibb (BMS) and University of Cambridge
(0.77)
-
Bristol-Myers Squibb (BMS) and University of Oxford
(0.71)
-
Bristol-Myers Squibb (BMS) and Wellcome Sanger Institute
(0.54)
-
Bristol-Myers Squibb (BMS) and IKA-Werke GmbH & CO. KG
(0.50)
-
Bristol-Myers Squibb (BMS) and The University of Manchester (UoM)
(0.49)
-
Bristol-Myers Squibb (BMS) and University of Navarra (UNAV)
(0.41)
-
Bristol-Myers Squibb (BMS) and ATDBio Ltd.
(0.40)
-
Bristol-Myers Squibb (BMS) and Health Innovation Manchester
(0.39)
Relationships
Bristol-Myers Squibb (BMS)
- BMS Australia
- BMS India
- Bristol-Myers Squibb Belgium S.A.
- Bristol-Myers Squibb Pharmaceuticals Limited UK
- Celgene Corporation
- Kosan Biosciences, Inc.
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.